Show simple item record

dc.contributor.authorPan American Health Organization
dc.description.abstractPAHO does not recommend oral or parenteral use of chlorine dioxide or sodium chlorite-based products for patients with suspected or diagnosed COVID-19 or for anyone else. There is no evidence of their effectiveness and the ingestion or inhalation of such products could cause serious adverse effects.
dc.subjectInfecctious Diseases
dc.titlePAHO Does Not Recommend Taking Products that Contain Chlorine Dioxide, Sodium Chlorite, Sodium Hypochlorite, or Derivatives, 16 July 2020
eihealth.countryRegional, Americas (PAHO/OPS)
eihealth.categoryInfection prevention and control, including health care workers protection
eihealth.typeWHO/PAHO Guidance
eihealth.maincategorySlow Spread / Reducir la Dispersión

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record